Clinical trial 1367.1
An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Boehringer Ingelheim |
| EudraCT Identifier | 2015-001111-12 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02516553 |
| Inclusion criteria | any line RECIST 1.1 |
| Last update |